Showing results (551-560 of 843) with videos related to
Sort By:
Pageof 85
Nature Communications|January 26, 2020
Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangementsRory Henderson, Maolin Lu, Ye Zhou, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2016
Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus MacaquesDonatella Negri, Maria Blasi, Celia LaBranche, et al.Journal of Virology|January 29, 2011
Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individualsAdam J Ritchie, Suzanne L Campion, Jakub Kopycinski, et al.Nature|January 1, 1999
Changes in thymic function with age and during the treatment of HIV infectionD C Douek, R D McFarland, P H Keiser, et al.Journal of Virology|February 6, 2009
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthXiaoying Shen, Robert J Parks, David C Montefiori, et al.Journal of Virological Methods|May 12, 2009
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodiesHua-Xin Liao, Marc C Levesque, Ashleigh Nagel, et al.Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestorsS Munir Alam, S Moses Dennison, Baptiste Aussedat, et al.Plos Pathogens|December 17, 2019
Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycansNelson R Wu, Nathan I Nicely, Esther M Lee, et al.Journal of Virology|June 26, 2009
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donorsElin S Gray, Natasha Taylor, Diane Wycuff, et al.Plos One|December 7, 2013
Pre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade CJeff Alexander, Jason Mendy, Lo Vang, et al.Pageof 85